2021 | H2 Equity Partners

H2 Equity Partners portfolio company Optegra Eye Health Care has acquired Top Esthetic and Vidium Medic

February 23, 2025December 16, 2021 by H2 Equity Partners

Optegra Eye Healthcare (“Optegra”) acquired Top Esthetic (“TE”) in August 2021 and Vidium Medica (“Vidium”) in December 2021. TE and Vidium are leading ophthalmology providers in the Czech and Polish markets respectively. Optegra generates circa £100 million sales and is a leading pan-European ophthalmology group with 27 eye care hospitals and 26 outpatient facilities. It … Read more

H2 Equity Partners agrees to carve-out of Acal BFI from Discoverie Group PLC

April 4, 2025November 10, 2021 by H2 Equity Partners

H2 Equity Partners (“H2”) is pleased to announce it has exchanged contracts with discoverIE Group plc to acquire Acal BFi, a leading pan-European provider of value-added design solutions, electronic components, and custom products across a broad range of technologies and applications. Completion of the acquisition will take place following the satisfaction of certain regulatory conditions. … Read more

H2 Equity Partners closes H2 Equity Partners Fund VI at £300 million and appoints Richard Dew and Cathal Turley to partner

February 23, 2025November 10, 2021 by H2 Equity Partners

H2 Equity Partners (“H2”) is pleased to announce that it has completed the fundraise process of H2 Equity Partners Fund VI, a new £300 million private equity fund. The first and final close was held on October 12th after a swift and efficient fundraise process that saw huge demand from existing investors that continue to support … Read more

H2 Equity Partners completes the sale of its shareholding in Healthcare 21

February 23, 2025April 12, 2021 by H2 Equity Partners

H2 Equity Partners completes the sale of its shareholding in Healthcare 21

H2 Equity Partners invests in Dales Marine

February 23, 2025January 8, 2021 by H2 Equity Partners

H2 Equity Partners invests In Dales Marine